ES8701761A1 - Un procedimiento para la preparacion de derivados de podofilotoxina. - Google Patents
Un procedimiento para la preparacion de derivados de podofilotoxina.Info
- Publication number
- ES8701761A1 ES8701761A1 ES550504A ES550504A ES8701761A1 ES 8701761 A1 ES8701761 A1 ES 8701761A1 ES 550504 A ES550504 A ES 550504A ES 550504 A ES550504 A ES 550504A ES 8701761 A1 ES8701761 A1 ES 8701761A1
- Authority
- ES
- Spain
- Prior art keywords
- podophyllotoxin
- derivatives
- illness
- treatment
- states
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Transplantation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
PROCEDIMIENTO PARA LA PREPARACION DE COMPUESTOS DE PODOFILOTOXINA Y DERIVADOS DE FORMULA (I) Y USO DE LOS COMPUESTOS PARA LA OBTENCION DE PREPARACIONES FARMACEUTICAS. EL COMPUESTO PODOFILOTOXINA SE EXTRAE DE LAS PLANTAS DEL GENERO PODOPHYLLUM (AUNQUE SE HA EMPLEADO HASTA AHORA UN EXTRACTO IMPURO DENOMINADO <PODOFILINA>), DE LOS RIZONAS, SECADOS Y FINALMENTE MOLIDOS, CON ACETATO DE ETILO Y EL EXTRACTO SE CONCENTRA Y SE FILTRA A TRAVES DEL GEL DE SILICE. LA FRACCION DESEADA SE CROMATOGRAFIA DESPUES SOBRE ALUMINA ACIDA Y SE PRODUCE UNA FRACCION QUE ENTRE OTROS COMPUESTOS CONTIENE PODOFILOTOXINA QUE SE AISLA DE LA MEZCLA POR CROMATOGRAFIA EN GEL DE SILICE Y DESPUES SE RECRISTALIZA. LA PODOFILOTOXINA Y SUS DERIVADOS SE UTILIZAN EN EL TRATAMIENTO DE ENFERMEDADES TROPICALES, ENFERMEDADES DE LA PIEL, REACCIONES DE RECHAZO EN TRANSPLANTES, COLAGENOSIS, ENFERMEDADES MENTALES (VIRUS) Y NEUROLOGICAS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8406660 | 1984-12-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
ES550504A0 ES550504A0 (es) | 1986-12-01 |
ES8701761A1 true ES8701761A1 (es) | 1986-12-01 |
Family
ID=20358339
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES550504A Expired ES8701761A1 (es) | 1984-12-28 | 1985-12-27 | Un procedimiento para la preparacion de derivados de podofilotoxina. |
Country Status (23)
Country | Link |
---|---|
US (1) | US4788216A (es) |
EP (1) | EP0207124B1 (es) |
JP (2) | JPH0720966B2 (es) |
CN (1) | CN1006795B (es) |
AP (1) | AP32A (es) |
AT (1) | ATE68186T1 (es) |
AU (1) | AU585936B2 (es) |
CA (1) | CA1255230A (es) |
DE (1) | DE3584370D1 (es) |
DK (1) | DK169506B1 (es) |
DZ (1) | DZ876A1 (es) |
EG (1) | EG17788A (es) |
ES (1) | ES8701761A1 (es) |
FI (1) | FI89330C (es) |
GR (1) | GR853145B (es) |
HU (1) | HU201672B (es) |
IL (1) | IL77456A (es) |
MA (1) | MA20602A1 (es) |
NO (1) | NO863329D0 (es) |
PT (1) | PT81760B (es) |
TN (1) | TNSN86004A1 (es) |
WO (1) | WO1986004062A1 (es) |
ZA (1) | ZA859881B (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4644072A (en) * | 1985-04-12 | 1987-02-17 | Bristol-Myers Company | Intermediates for the production of epipodophyllotoxin and related compounds and processes for the preparation and use thereof |
EP0461141B1 (en) * | 1989-02-23 | 1999-11-03 | University Of North Carolina At Chapel Hill | Etoposide analogues |
SE464167B (sv) | 1989-07-31 | 1991-03-18 | Analytecon Sa | Topisk farmaceutisk beredning av podophyllotoxin |
US5332811A (en) * | 1989-09-12 | 1994-07-26 | The University Of North Carolina At Chapel Hill | Etopside analogs |
US5338867A (en) * | 1992-04-24 | 1994-08-16 | Genelabs Technologies, Inc. | Preparation of 4β- amino podophyllotoxin compounds |
SE9301831D0 (sv) * | 1993-05-28 | 1993-05-28 | Analytecon S A | Pharmaceutical compositions |
GB9422947D0 (en) * | 1994-11-14 | 1995-01-04 | Univ Salamanca | Immunosuppressive cyclolignan derivatives |
US6051721A (en) * | 1997-10-02 | 2000-04-18 | The Board Of Regents Of The University Of Nebraska | Ring E-modified analogues of(-)-podophyllotoxin and etoposide and a method for their synthesis |
FI105152B (fi) * | 1998-07-17 | 2000-06-30 | Eero Saarela | Paikallinen kivunlievitysmenetelmä |
US6143304A (en) * | 1999-08-17 | 2000-11-07 | The University Of Mississippi | Enhanced yield of podophyllotoxin from natural products through in situ conversion methods |
SE0102168D0 (sv) | 2001-06-19 | 2001-06-19 | Karolinska Innovations Ab | New use and new compounds |
DE60233601D1 (de) * | 2001-06-19 | 2009-10-15 | Axelar Ab | Verwendung von bestimmten Cyclolignanen |
SE0203746D0 (sv) * | 2002-12-18 | 2002-12-18 | Karolinska Innovations Ab | New compounds |
AU2009263074A1 (en) * | 2008-06-23 | 2009-12-30 | Axelar Ab | Use of cyclolignans for the treatment of a hyperactive immune system |
WO2013124380A1 (en) * | 2012-02-24 | 2013-08-29 | Nestec S.A. | Peltatin for the treatment of chronic inflammatory disorders |
WO2015028456A1 (en) * | 2013-08-28 | 2015-03-05 | Nestec S.A. | PPAR modulators |
JOP20190254A1 (ar) | 2017-04-27 | 2019-10-27 | Pharma Mar Sa | مركبات مضادة للأورام |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA635769A (en) * | 1962-01-30 | Rutschmann Jurg | Amides of podophyllic acid and picropodophyllic acid | |
SE335139B (es) * | 1964-08-12 | 1971-05-17 | Sandoz Ag | |
US4122092A (en) * | 1977-08-25 | 1978-10-24 | University Of Rochester | Total synthesis of (±)-picropodophyllone and (±)-4'-demethylpicropodophyllone |
US4567253A (en) * | 1984-02-03 | 1986-01-28 | Tony Durst | 2-Substituted derivatives of podophyllotoxin and etoposide |
GB8424269D0 (en) * | 1984-09-26 | 1984-10-31 | Pharma Medica As | Isolation and purification of podophyllotoxin |
-
1985
- 1985-12-20 AU AU53003/86A patent/AU585936B2/en not_active Ceased
- 1985-12-20 DE DE8686900345T patent/DE3584370D1/de not_active Expired - Fee Related
- 1985-12-20 US US06/908,801 patent/US4788216A/en not_active Expired - Lifetime
- 1985-12-20 AT AT86900345T patent/ATE68186T1/de not_active IP Right Cessation
- 1985-12-20 EP EP86900345A patent/EP0207124B1/en not_active Expired - Lifetime
- 1985-12-20 HU HU86777D patent/HU201672B/hu not_active IP Right Cessation
- 1985-12-20 JP JP61500490A patent/JPH0720966B2/ja not_active Expired - Lifetime
- 1985-12-20 WO PCT/SE1985/000541 patent/WO1986004062A1/en active IP Right Grant
- 1985-12-23 AP APAP/P/1985/000017A patent/AP32A/en active
- 1985-12-24 CA CA000498645A patent/CA1255230A/en not_active Expired
- 1985-12-25 EG EG828/85A patent/EG17788A/xx active
- 1985-12-26 MA MA20828A patent/MA20602A1/fr unknown
- 1985-12-26 PT PT81760A patent/PT81760B/pt not_active IP Right Cessation
- 1985-12-26 IL IL77456A patent/IL77456A/xx unknown
- 1985-12-27 ES ES550504A patent/ES8701761A1/es not_active Expired
- 1985-12-27 GR GR853145A patent/GR853145B/el not_active IP Right Cessation
- 1985-12-27 CN CN85109666A patent/CN1006795B/zh not_active Expired
- 1985-12-28 DZ DZ850275A patent/DZ876A1/fr active
- 1985-12-30 ZA ZA859881A patent/ZA859881B/xx unknown
-
1986
- 1986-01-09 TN TNTNSN86004A patent/TNSN86004A1/fr unknown
- 1986-08-19 NO NO1986863329A patent/NO863329D0/no unknown
- 1986-08-27 FI FI863482A patent/FI89330C/fi not_active IP Right Cessation
- 1986-08-27 DK DK408186A patent/DK169506B1/da not_active IP Right Cessation
-
1994
- 1994-10-14 JP JP6274258A patent/JP2572558B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8701761A1 (es) | Un procedimiento para la preparacion de derivados de podofilotoxina. | |
IE860077L (en) | Glycosidic derivatives | |
IE853218L (en) | Piperazine derivatives-pharmaceutical compositions | |
JPS5610592A (en) | Production of molybdenum containing composition | |
ES8406881A1 (es) | Procedimiento para la preparacion de 4-amino-metileno-cromanos y -cromenos sustituidos | |
ES8502987A1 (es) | Procedimiento para preparar nuevos benzo (b) tiofenos | |
EP0165458A3 (en) | (+)-ambrox, process for production thereof and use thereof | |
GB8813979D0 (en) | Water based flame-proofing composition & method of manufacture | |
EP0144991A3 (en) | Polymethosybenzyl piperazine derivatives, processes for their preparation and pharmaceutical compositions containing said derivatives | |
ES8607263A1 (es) | Un procedimiento de preparacion de compuestos heterociclicos | |
AU532435B2 (en) | Dental compositions | |
AU521051B2 (en) | Purification of crude chlorophosphazene compounds by treatment with water | |
NZ212658A (en) | Phenylnaphthyridine derivatives and pharmaceutical compositions | |
JPS567799A (en) | Novel pseudotrisaccharide* its manufacture and use as medicine | |
ES8104222A1 (es) | Un procedimiento para la preparacion de derivados del acido 7-oxo-1-aza-biciclo (3,2,0) hept-2-en-2-carboxilico | |
HUT49892A (en) | Process for production of new organic compositions | |
JPS5419969A (en) | Proline derivative and its preparation | |
JPS5473789A (en) | 2,6-diphenyl-3,7-dioxabicyclo-3.3.0-octane 4,8-dione derivative and anticarcinogens, catechol-o-methyl transferase inhibitors and adenosine 3',5'-cyclic phosphoric acid phosphodiesterase inhibitors containing the derivative as active component | |
ES8306481A1 (es) | Procedimiento para la obtencion de sulfamidas anulares. | |
AU565187B2 (en) | 2-n-cycloalkylmethyl-3-oxo-5,6-diaryl-as-triazines | |
JPS51123824A (en) | A non-medical antibacterial and its preparation | |
JPS5427578A (en) | 1-carboxyalkylcarbamoyl-5-fluorouracil derivatives and their preparation | |
JPS53130693A (en) | Antibiotic substance c-15003 | |
JPS5419985A (en) | Production of hydroxycarbostyril derivative | |
DE3275465D1 (en) | Thiolactime ethers of delta-1-pyrrolidine, and their preparation |